BIA
ARNA

Bell Investment Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bell Investment Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1K Sell
15
-17
-53% -$1.12K ﹤0.01% 1739
2021
Q3 		$2K Buy
+32
New +$1.89K ﹤0.01% 1221

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bell Investment Advisors's ARNA Position: Q4 2021 in Review

Bell Investment Advisors reduced its Arena Pharmaceuticals Inc (ARNA) stake by 53% in Q4 2021, selling an estimated $1.12K and leaving 15 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Bell Investment Advisors first reported a position in ARNA in Q3 2021 and has held it in 2 quarters since. The position peaked at $2K in Q3 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Bell Investment Advisors held 15 shares of Arena Pharmaceuticals Inc worth $1K as of Q4 2021.
  • Bell Investment Advisors sold 17 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $1.12K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of Bell Investment Advisors's portfolio in Q4 2021, its #1739 holding.
  • Bell Investment Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2021 and has held it in 2 quarters since.
  • Bell Investment Advisors's Arena Pharmaceuticals Inc position peaked at $2K in Q3 2021.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Bell Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.